Paradoxical instability-activity relationship defines a novel regulatory pathway for retinoblastoma proteins

Molecular Biology of the Cell

Volumn 21, Issue 22, 2010, Pages 3890-3901

  Acharya, Pankaj ^a   Raj, Nitin ^c   Buckley, Martin S ^c   Zhang, Liang ^c   Duperon, Stephanie ^b   Williams, Geoffrey ^d   Henry, R William ^b   Arnosti, David N ^b  

^a Michigan State University ^*  (United States)

^b Michigan State University   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P107; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; DROSOPHILA; ENZYME REPRESSION; FEMALE; LARVA; MALE; MAMMAL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, WESTERN; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; E2F TRANSCRIPTION FACTORS; EYE; FEMALE; LARVA; LEUPEPTINS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STABILITY; REGULATORY SEQUENCES, NUCLEIC ACID; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 78649647535     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-06-0520     Document Type: Article

References (44)

1. Binne, U. K., Classon, M. K., Dick, F. A., Wei, W., Rape, M., Kaelin, W. G., Jr., Naar, A. M., and Dyson, N. J. (2007). Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat. Cell. Biol. 9, 225-232.
2. Boyer, S. N., Wazer, D. E., and Band, V. (1996). E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin- proteasome pathway. Cancer Res. 56, 4620-4624.
3. Brand, A. H., and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415.
4. Chang, E. C., and Schwechheimer, C. (2004). ZOMES III: the interface between signalling and proteolysis. Meeting on The COP9 Signalosome, Proteasome and eIF3. EMBO Rep. 5, 1041-1045.
5. Classon, M., and Harlow, E. (2002). The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer. 2, 910-917.
6. Collins, G. A., and Tansey, W. P. (2006). The proteasome: a utility tool for transcription? Curr. Opin. Genet. Dev. 16, 197-202.
7. Daulny, A., Geng, F., Muratani, M., Geisinger, J. M., Salghetti, S. E., and Tansey, W. P. (2008). Modulation of RNA polymerase II subunit composition by ubiquitylation. Proc. Natl. Acad. Sci. USA. 105, 19649-19654.
8. Dimova, D. K., Stevaux, O., Frolov, M. V., and Dyson, N. J. (2003). Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev. 17, 2308-2320.
9. Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
10. Ferdous, A., Sikder, D., Gillette, T., Nalley, K., Kodadek, T., and Johnston, S. A. (2007). The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters. Genes Dev. 21, 112-123.
11. Frolov, M. V., Moon, N. S., and Dyson, N. J. (2005). dDP is needed for normal cell proliferation. Mol. Cell. Biol. 25, 3027-3039.
12. Gilbert, M. K., Tan, Y. Y., and Hart, C. M. (2006). The Drosophila boundary element-associated factors BEAF-32A and BEAF-32B affect chromatin structure. Genetics 173, 1365-1375.
13. Gonzalez, F., Delahodde, A., Kodadek, T., and Johnston, S. A. (2002). Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296, 548-550.
14. Hiebert, S. W., Chellappan, S. P., Horowitz, J. M., and Nevins, J. R. (1992). The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6, 177-185.
15. Ji, P., Jiang, H., Rekhtman, K., Bloom, J., Ichetovkin, M., Pagano, M., and Zhu, L. (2004). An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell. 16, 47-58.
16. Keller, S. A., Ullah, Z., Buckley, M. S., Henry, R. W., and Arnosti, D. N. (2005). Distinct developmental expression of Drosophila retinoblastoma factors. Gene. Expr. Patterns. 5, 411-421.
17. Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E., and Tansey, W. P. (2003). Skp2 regulates Myc protein stability and activity. Mol. Cell. 11, 1177-1188.
18. Knudson, A. G., Jr. (1978). Retinoblastoma: a prototypic hereditary neoplasm. Semin. Oncol. 5, 57-60.
19. Lee, C., Chang, J. H., Lee, H. S., and Cho, Y. (2002). Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev. 16, 3199-3212. (Pubitemid 36025973)
20. Lee, D., Ezhkova, E., Li, B., Pattenden, S. G., Tansey, W. P., and Workman, J. L. (2005). The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell 123, 423-436.
21. Lohmann, D. R. (1999). RB1 gene mutations in retinoblastoma. Hum. Mutat. 14, 283-288.
22. Martinez, C. A., and Arnosti, D. N. (2008). Spreading of a corepressor linked to action of long-range repressor hairy. Mol. Cell. Biol. 28, 2792-2802.
23. Muratani, M., and Tansey, W. P. (2003). How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell. Biol. 4, 192-201.
24. Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., and Glass, C. K. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437, 759-763.
25. Prince, A. M., May, J. S., Burton, G. R., Lyle, R. E., and McGehee, R. E., Jr. (2002). Proteasomal degradation of retinoblastoma-related p130 during adipocyte differentiation. Biochem. Biophys. Res. Commun. 290, 1066-1071.
26. Rubin, S. M., Gall, A. L., Zheng, N., and Pavletich, N. P. (2005). Structure of the Rb C-terminal domain bound to E2F1-DP 1, a mechanism for phosphorylation-induced E2F release. Cell 123, 1093-1106.
27. Ryu, J. R., and Arnosti, D. N. (2003). Functional similarity of Knirps CtBP-dependent and CtBP-independent transcriptional repressor activities. Nucleic Acids Res. 31, 4654-4662.
28. Salghetti, S. E., Caudy, A. A., Chenoweth, J. G., and Tansey, W. P. (2001). Regulation of transcriptional activation domain function by ubiquitin. Science 293, 1651-1653. (Pubitemid 32807843)
29. Salghetti, S. E., Kim, S. Y., and Tansey, W. P. (1999). Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18, 717-726.
30. Salghetti, S. E., Muratani, M., Wijnen, H., Futcher, B., and Tansey, W. P. (2000). Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc. Natl. Acad. Sci. USA. 97, 3118-3123.
31. Schejter, E. D., and Shilo, B. Z. (1989). The Drosophila EGF receptor homolog (DER) gene is allelic to faint little ball, a locus essential for embryonic development. Cell 56, 1093-1104.
32. Sdek, P., Ying, H., Chang, D. L., Qiu, W., Zheng, H., Touitou, R., Allday, M. J., and Xiao, Z. X. (2005). MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol. Cell. 20, 699-708.
33. Stevaux, O., Dimova, D., Frolov, M. V., Taylor-Harding, B., Morris, E., and Dyson, N. (2002). Distinct mechanisms of E2F regulation by Drosophila RBF1 and RBF2. EMBO J. 21, 4927-4937.
34. Stevaux, O., Dimova, D. K., Ji, J. Y., Moon, N. S., Frolov, M. V., and Dyson, N. J. (2005). Retinoblastoma family 2 is required in vivo for the tissue-specific repression of dE2F2 target genes. Cell. Cycle. 4, 1272-1280.
35. Stubdal, H., Zalvide, J., Campbell, K. S., Schweitzer, C., Roberts, T. M., and DeCaprio, J. A. (1997). Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol. Cell. Biol. 17, 4979-4990.
36. Su, H. W., Qu, L. J., Chen, Z. L., and Gu, H. Y. (2003). Evolution of COP9 signalosome and proteasome lid complex. Acta. Botanica Sinica. 45, 523-529.
37. Sutcliffe, J. E., Korenjak, M., and Brehm, A. (2003). Tumour suppressors-a fly's perspective. Eur. J. Cancer. 39, 1355-1362.
38. Swanhart, L. M., Sanders, A. N., and Duronio, R. J. (2007). Normal regulation of Rbf1/E2f1 target genes in Drosophila type 1 protein phosphatase mutants. Dev. Dyn. 236, 2567-2577.
39. Uchida, C., Miwa, S., Kitagawa, K., Hattori, T., Isobe, T., Otani, S., Oda, T., Sugimura, H., Kamijo, T., Ookawa, K., Yasuda, H., and Kitagawa, M. (2005). Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation. EMBO J. 24, 160-169. (Pubitemid 40188473)
40. Ullah, Z., Buckley, M. S., Arnosti, D. N., and Henry, R. W. (2007). Retinoblastoma protein regulation by the COP9 signalosome. Mol. Biol. Cell. 18, 1179-1186.
41. van den Heuvel, S., and Dyson, N. J. (2008). Conserved functions of the pRB and E2F families. Nat. Rev. Mol. Cell. Biol. 9, 713-724.
42. Wei, N., Serino, G., and Deng, X. W. (2008). The COP9 signalosome: more than a protease. Trends Biochem. Sci. 33, 592-600.
43. Xiao, B., Spencer, J., Clements, A., Ali-Khan, N., Mittnacht, S., Broceno, C., Burghammer, M., Perrakis, A., Marmorstein, R., and Gamblin, S. J. (2003). Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc. Natl. Acad. Sci. USA. 100, 2363-2368.
44. Xin, S., Weng, L., Xu, J., and Du, W. (2002). The role of RBF in developmentally regulated cell proliferation in the eye disc and in Cyclin D/Cdk4 induced cellular growth. Development 129, 1345-1356. (Pubitemid 34874156)